CONQUEST: A Platform Clinical Trial for Scleroderma-Associated Lung Disease
Offered By: SRFCURE via YouTube
Course Description
Overview
Learn about CONQUEST, an innovative phase 2b international platform clinical trial accelerating scleroderma research. Explore how this multicenter study, developed by the SRF and partner biopharmaceutical companies, investigates multiple therapies for treating interstitial lung disease (ILD) associated with systemic sclerosis (SSc-ILD). Gain insights from experts Dr. Toby Maher, Professor of Clinical Medicine at Keck School of Medicine of USC, and Dr. Dinesh Khanna, Professor of Medicine at the University of Michigan, as they present the groundbreaking approach to advancing treatments for this complex condition.
Syllabus
CONQUEST, a Platform Clinical Trial
Taught by
SRFCURE
Related Courses
Going Out on a Limb: The Anatomy of the Upper LimbUniversity of Pennsylvania via Coursera On Demand: Yale Rheumatology State of the Art Symposium - Reactive Arthritis, Post-Infections, Inflammatory Disease, and Lessons for COVID
Yale University via Independent Medicine Grand Rounds - Cardiovascular Safety of Urate-Lowering Drugs in Gout
Dartmouth College via Independent Introduction to Imaging of Arthritis
Stanford University via Independent Radiography of Arthritis
Stanford University via Independent